Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133 <sup>+</sup> cells in clear cell renal carcinoma
John R. Bradley(University of Cambridge), Rafia S. Al‐Lamki(University of Cambridge)
Cited by 13
Related Papers
Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource
|Nature Genetics|2009|279
Germline selection shapes human mitochondrial DNA diversity
|Science|2019|251
A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss
|Blood|2016|156
A dominant gain-of-function mutation in universal tyrosine kinase <i>SRC</i> causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
|Science Translational Medicine|2016|144
Expression of Tumor Necrosis Factor Receptors in Normal Kidney and Rejecting Renal Transplants
|Laboratory Investigation|2001|135